Trump health chief renews call to end key drug-pricing tactic
By
Anna Edney
Published
4 Min Read
Anna Edney
From
Bloomberg
More From Employee Benefit News
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Benefits Think Preparing benefits for the next wave: Gene therapy medications
As the scope of gene therapy grows, understanding their impact and cost can help organizations decide how to cover them through their healthcare plans.
Benefits Think PBM playbook, part 2: Changes to the market and the value of a pharmacy benefits expert
A look at traditional PBMs and pass-through models, potential savings areas, developments and partnering with the right consultant.
Benefits Think Rewriting the PBM playbook: Exposing hidden costs and empowering plan sponsors
Part one of this two-part series looks at the background, transparency solutions and how to understand PBM profitability.
Benefits Think How employers end up paying for weight gain
When GLP-1s are offered without expert clinical and lifestyle support, they lose effectiveness and lead to wasted money.
